AptarGroup (ATR) | Financial Analysis & Statements
AptarGroup, Inc. Mid-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Revenue
962.7M
Gross Profit
338.2M
35.13%
Operating Income
110.3M
11.46%
Net Income
74.3M
7.71%
EPS (Diluted)
$1.13
Balance Sheet Metrics
Total Assets
5.3B
Total Liabilities
2.5B
Shareholders Equity
2.7B
Debt to Equity
0.94
Cash Flow Metrics
Operating Cash Flow
152.4M
Free Cash Flow
96.2M
Revenue & Profitability Trend
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
AptarGroup Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 3.8B | 3.6B | 3.5B | 3.3B | 3.2B |
| Cost of Goods Sold | 2.4B | 2.2B | 2.2B | 2.2B | 2.1B |
| Gross Profit | 1.4B | 1.4B | 1.3B | 1.2B | 1.2B |
| Gross Margin % | 37.2% | 37.8% | 36.2% | 35.0% | 35.8% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | - |
| Selling, General & Administrative | 606.5M | 582.2M | 565.8M | 544.3M | 551.2M |
| Other Operating Expenses | - | - | - | - | - |
| Total Operating Expenses | 606.5M | 582.2M | 565.8M | 544.3M | 551.2M |
| Operating Income | 510.9M | 509.5M | 449.0M | 385.9M | 370.6M |
| Operating Margin % | 13.5% | 14.2% | 12.9% | 11.6% | 11.5% |
| Non-Operating Items | |||||
| Interest Income | 11.7M | 12.1M | 4.4M | 2.7M | 3.7M |
| Interest Expense | 52.7M | 43.9M | 40.4M | 40.8M | 30.3M |
| Other Non-Operating Income | 21.6M | -7.9M | -38.2M | -13.0M | -22.3M |
| Pre-tax Income | 491.4M | 469.8M | 374.8M | 334.7M | 321.7M |
| Income Tax | 98.9M | 95.6M | 90.6M | 95.1M | 78.0M |
| Effective Tax Rate % | 20.1% | 20.3% | 24.2% | 28.4% | 24.3% |
| Net Income | 392.5M | 374.2M | 284.2M | 239.6M | 243.6M |
| Net Margin % | 10.4% | 10.4% | 8.1% | 7.2% | 7.5% |
| Key Metrics | |||||
| EBITDA | 841.8M | 788.7M | 707.4M | 617.9M | 605.3M |
| EPS (Basic) | $5.97 | $5.65 | $4.34 | $3.66 | $3.72 |
| EPS (Diluted) | $5.89 | $5.53 | $4.25 | $3.59 | $3.61 |
| Basic Shares Outstanding | 65740000 | 66334000 | 65616000 | 65402000 | 65663000 |
| Diluted Shares Outstanding | 65740000 | 66334000 | 65616000 | 65402000 | 65663000 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
AptarGroup Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 402.4M | 223.8M | 223.6M | 141.7M | 122.9M |
| Short-term Investments | 7.1M | 2.3M | - | 0 | 740.0K |
| Accounts Receivable | 803.8M | 658.1M | 677.8M | 677.0M | 671.4M |
| Inventory | 537.8M | 461.8M | 513.1M | 486.8M | 441.5M |
| Other Current Assets | 142.4M | 132.3M | 134.8M | 124.8M | 121.7M |
| Total Current Assets | 1.9B | 1.5B | 1.5B | 1.4B | 1.4B |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 65.7M | 64.2M | 59.1M | 58.7M | 62.5M |
| Goodwill | 2.4B | 2.1B | 2.2B | 2.2B | 2.3B |
| Intangible Assets | 255.3M | 254.8M | 283.2M | 315.7M | 362.3M |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 152.7M | 105.2M | 69.6M | 57.1M | 48.8M |
| Total Non-Current Assets | 3.4B | 3.0B | 2.9B | 2.8B | 2.8B |
| Total Assets | 5.3B | 4.4B | 4.5B | 4.2B | 4.1B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 340.6M | 296.0M | 328.6M | 320.3M | 285.3M |
| Short-term Debt | 343.5M | 338.3M | 458.2M | 122.8M | 289.6M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | - | - | - | - | - |
| Total Current Liabilities | 1.2B | 1.1B | 1.3B | 917.2M | 982.5M |
| Non-Current Liabilities | |||||
| Long-term Debt | 1.2B | 737.8M | 726.5M | 1.1B | 955.0M |
| Deferred Tax Liabilities | 19.6M | 14.3M | 19.0M | 20.6M | 27.5M |
| Other Non-Current Liabilities | 99.4M | 63.8M | 71.0M | 53.0M | 74.9M |
| Total Non-Current Liabilities | 1.4B | 878.1M | 879.3M | 1.2B | 1.2B |
| Total Liabilities | 2.5B | 1.9B | 2.1B | 2.1B | 2.2B |
| Equity | |||||
| Common Stock | 728.0K | 725.0K | 717.0K | 709.0K | 704.0K |
| Retained Earnings | 2.6B | 2.4B | 2.1B | 1.9B | 1.8B |
| Treasury Stock | 954.3M | 595.8M | 539.4M | 503.3M | 421.2M |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 2.7B | 2.5B | 2.3B | 2.1B | 2.0B |
| Key Metrics | |||||
| Total Debt | 1.5B | 1.1B | 1.2B | 1.2B | 1.2B |
| Working Capital | 727.1M | 410.1M | 298.0M | 513.1M | 375.7M |
Balance Sheet Composition
AptarGroup Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 392.5M | 374.2M | 284.2M | 239.6M | 243.6M |
| Depreciation & Amortization | 287.4M | 263.8M | 248.6M | 233.7M | 234.9M |
| Stock-Based Compensation | 43.9M | 47.6M | 41.3M | 40.9M | 38.9M |
| Working Capital Changes | -121.3M | -34.0M | 18.0M | -55.3M | -159.5M |
| Operating Cash Flow | 590.8M | 630.2M | 572.1M | 438.2M | 346.2M |
| Investing Activities | |||||
| Capital Expenditures | 3.5M | 1.5M | 5.3M | 93.0K | 5.2M |
| Acquisitions | -60.2M | 0 | -16.6M | -4.1M | -148.4M |
| Investment Purchases | -8.7M | -101.3M | 0 | 0 | -7.4M |
| Investment Sales | 5.8M | 0 | 5.6M | 2.3M | 2.4M |
| Investing Cash Flow | -56.0M | -102.5M | -6.1M | 20.0M | -149.3M |
| Financing Activities | |||||
| Share Repurchases | -365.0M | -68.6M | -47.6M | -92.1M | -78.1M |
| Dividends Paid | -120.8M | -114.1M | -103.7M | -99.5M | -98.5M |
| Debt Issuance | 631.2M | 190.9M | 25.9M | 452.0M | 26.6M |
| Debt Repayment | -194.8M | -397.2M | -154.5M | -303.9M | -82.5M |
| Financing Cash Flow | -96.4M | -280.2M | -225.5M | -190.6M | -141.4M |
| Free Cash Flow | 294.6M | 349.2M | 256.8M | 163.0M | 55.5M |
| Net Change in Cash | 438.4M | 247.6M | 340.5M | 267.6M | 55.5M |
Cash Flow Trend
AptarGroup Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
21.10
Forward P/E
19.49
Price to Book
2.99
Price to Sales
2.11
PEG Ratio
-0.84
Profitability Ratios
Profit Margin
10.40%
Operating Margin
11.25%
Return on Equity
15.10%
Return on Assets
6.66%
Financial Health
Current Ratio
1.62
Debt to Equity
57.10
Beta
0.49
Per Share Data
EPS (TTM)
$5.88
Book Value per Share
$41.56
Revenue per Share
$57.46
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| ATR | 8.0B | 21.10 | 2.99 | 15.10% | 10.40% | 57.10 |
| Intuitive Surgical | 170.1B | 54.97 | 8.99 | 16.69% | 28.38% | 0.95 |
| Becton, Dickinson | 56.1B | 25.40 | 1.75 | 6.96% | 8.01% | 77.28 |
| Baxter International | 9.4B | 86.31 | 1.54 | -13.71% | -8.51% | 160.28 |
| Repligen | 7.5B | 154.30 | 3.55 | 2.40% | 6.62% | 32.76 |
| Teleflex | 6.0B | 104.31 | 1.93 | 1.58% | -45.45% | 90.32 |
Financial data is updated regularly. All figures are in the company's reporting currency.






